These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12911461)

  • 1. NMDA-mediated mechanisms in cortical excitability changes after limb amputation.
    Schwenkreis P; Maier C; Pleger B; Mansourian N; Dertwinkel R; Malin JP; Tegenthoff M; Zenz M
    Acta Neurol Scand; 2003 Sep; 108(3):179-84. PubMed ID: 12911461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous brachial plexus blockade in combination with the NMDA receptor antagonist memantine prevents phantom pain in acute traumatic upper limb amputees.
    Schley M; Topfner S; Wiech K; Schaller HE; Konrad CJ; Schmelz M; Birbaumer N
    Eur J Pain; 2007 Apr; 11(3):299-308. PubMed ID: 16716615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A placebo-controlled randomized crossover trial of the N-methyl-D-aspartic acid receptor antagonist, memantine, in patients with chronic phantom limb pain.
    Wiech K; Kiefer RT; Töpfner S; Preissl H; Braun C; Unertl K; Flor H; Birbaumer N
    Anesth Analg; 2004 Feb; 98(2):408-413. PubMed ID: 14742379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of cortical excitability in patients with upper limb amputation.
    Schwenkreis P; Witscher K; Janssen F; Dertwinkel R; Zenz M; Malin JP; Tegenthoff M
    Neurosci Lett; 2000 Oct; 293(2):143-6. PubMed ID: 11027854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding intracortical excitability in phantom limb pain: A multivariate analysis from a multicenter randomized clinical trial.
    Teixeira PEP; Pacheco-Barrios K; Gunduz ME; Gianlorenço AC; Castelo-Branco L; Fregni F
    Neurophysiol Clin; 2021 Mar; 51(2):161-173. PubMed ID: 33648819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of the NMDA-receptor antagonist memantine in patients with chronic phantom limb pain--results of a randomized double-blinded, placebo-controlled trial.
    Maier C; Dertwinkel R; Mansourian N; Hosbach I; Schwenkreis P; Senne I; Skipka G; Zenz M; Tegenthoff M
    Pain; 2003 Jun; 103(3):277-283. PubMed ID: 12791434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of the N-methyl-D-aspartate antagonist memantine on human motor cortex excitability.
    Schwenkreis P; Witscher K; Janssen F; Addo A; Dertwinkel R; Zenz M; Malin JP; Tegenthoff M
    Neurosci Lett; 1999 Aug; 270(3):137-40. PubMed ID: 10462113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of human motor cortex excitability by single doses of amantadine.
    Reis J; John D; Heimeroth A; Mueller HH; Oertel WH; Arndt T; Rosenow F
    Neuropsychopharmacology; 2006 Dec; 31(12):2758-66. PubMed ID: 16794570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reorganization of cortical blood flow and transcranial magnetic stimulation maps in human subjects after upper limb amputation.
    Kew JJ; Ridding MC; Rothwell JC; Passingham RE; Leigh PN; Sooriakumaran S; Frackowiak RS; Brooks DJ
    J Neurophysiol; 1994 Nov; 72(5):2517-24. PubMed ID: 7884476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Memantine (a N-methyl-D-aspartate receptor antagonist) in the treatment of neuropathic pain after amputation or surgery: a randomized, double-blinded, cross-over study.
    Nikolajsen L; Gottrup H; Kristensen AG; Jensen TS
    Anesth Analg; 2000 Oct; 91(4):960-6. PubMed ID: 11004057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and functional motor cortex asymmetry in unilateral lower limb amputation with phantom limb pain.
    Pacheco-Barrios K; Pinto CB; Saleh Velez FG; Duarte D; Gunduz ME; Simis M; Lepesteur Gianlorenco AC; Barouh JL; Crandell D; Guidetti M; Battistella L; Fregni F
    Clin Neurophysiol; 2020 Oct; 131(10):2375-2382. PubMed ID: 32828040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcranial magnetic stimulation in subjects with phantom pain and non-painful phantom sensations: A systematic review.
    Nardone R; Versace V; Sebastianelli L; Brigo F; Christova M; Scarano GI; Saltuari L; Trinka E; Hauer L; Sellner J
    Brain Res Bull; 2019 May; 148():1-9. PubMed ID: 30862485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dextromethorphan mitigates phantom pain in cancer amputees.
    Ben Abraham R; Marouani N; Weinbroum AA
    Ann Surg Oncol; 2003 Apr; 10(3):268-74. PubMed ID: 12679312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Memantine for the Treatment of Phantom Limb Pain: A Systematic Review.
    Loy BM; Britt RB; Brown JN
    J Pain Palliat Care Pharmacother; 2016 Dec; 30(4):276-283. PubMed ID: 27813692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P300-amplitudes in upper limb amputees with and without phantom limb pain in a visual oddball paradigm.
    Karl A; Diers M; Flor H
    Pain; 2004 Jul; 110(1-2):40-8. PubMed ID: 15275750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute and chronic effects of single dose memantine after controlled cortical impact injury in adult rats.
    Abrahamson EE; Poloyac SM; Dixon CE; Dekosky ST; Ikonomovic MD
    Restor Neurol Neurosci; 2019; 37(3):245-263. PubMed ID: 31177251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phantom-limb pain as a perceptual correlate of cortical reorganization following arm amputation.
    Flor H; Elbert T; Knecht S; Wienbruch C; Pantev C; Birbaumer N; Larbig W; Taub E
    Nature; 1995 Jun; 375(6531):482-4. PubMed ID: 7777055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postamputation pain: studies on mechanisms.
    Nikolajsen L
    Dan Med J; 2012 Oct; 59(10):B4527. PubMed ID: 23158899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of memantine on event-related potential, oscillations, and complexity in individuals with and without family histories of alcoholism.
    Narayanan B; Stevens MC; Jiantonio RE; Krystal JH; Pearlson GD
    J Stud Alcohol Drugs; 2013 Mar; 74(2):245-57. PubMed ID: 23384372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro galantamine-memantine co-application: mechanism of beneficial action.
    Zhao X; Marszalec W; Toth PT; Huang J; Yeh JZ; Narahashi T
    Neuropharmacology; 2006 Dec; 51(7-8):1181-91. PubMed ID: 17011596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.